Life Science Connect (LSC) has appointed Sean Griffey to its Board of Directors. This strategic move strengthens LSC’s B2B media platform and expands its commercial capabilities across the life sciences sector. LSC is a portfolio company of Latticework Capital Management and Edgehill Management.
Who Is Life Science Connect?
A Trusted Network for Life Sciences Professionals
LSC operates from its headquarters in Pittsburgh, Pennsylvania. The company runs a network of editorial communities and events that serve professionals across the life sciences industry. Through independent journalism and expert-driven content, LSC builds engaged audiences. These audiences, in turn, inform critical decisions across research, development, manufacturing, and commercialisation.
Moreover, LSC’s model is rooted in the strength of its editorial communities. Its commercial programmes help suppliers connect with these audiences in meaningful, data-driven ways. Consequently, LSC serves as a critical bridge between industry knowledge and commercial engagement.
Sean Griffey: A Proven B2B Media Leader
From Industry Dive to Life Science Connect
Sean Griffey is a co-founder and former CEO of Industry Dive. Under his leadership, Industry Dive grew rapidly into a major B2B media powerhouse. The company expanded to more than 20 targeted publications. It served millions of executive readers before Informa PLC acquired it in 2022.
Before Industry Dive, Griffey served as President of FierceMarkets. There, he led the company’s growth and its eventual sale to Questex Media Group. He holds a B.S. in Economics from Penn State and an MBA from Northwestern’s Kellogg School of Management. Furthermore, Griffey is widely recognised for his operational expertise, his commitment to quality journalism, and his ability to scale digital media businesses.
A Track Record Built on Culture and Clarity
Griffey’s approach to leadership has always prioritised strong organisational culture alongside strategic clarity. These values helped him build Industry Dive into a trusted name in professional media. As a result, his appointment to the LSC board signals a clear intent to replicate that success in the life sciences space.
What Griffey Brings to the LSC Board
Scaling Editorial Communities with Commercial Precision
Griffey’s experience building trusted editorial audiences is directly aligned with LSC’s business model. His background in scaling digital media platforms will support the continued growth of Life Science Connect’s editorial communities. Additionally, it will advance LSC’s broader commercial model.
“I’m honoured to join the Life Science Connect board and support its mission of strengthening the life sciences community by connecting people, ideas, and innovation,” said Griffey. “I look forward to working with the team to support its continued growth and impact.”
His expertise offers LSC three core advantages. First, he brings deep knowledge of audience development in niche B2B verticals. Second, he understands how to monetise editorial communities without compromising their integrity. Third, he has successfully navigated large-scale acquisitions, which is valuable as LSC continues its own expansion.
Leadership Voices on the Appointment
CEO Jon Howland Welcomes the Addition
Jon Howland, CEO of Life Science Connect, expressed strong enthusiasm for the new board member. “We’re delighted to welcome Sean Griffey to the Life Science Connect Board of Directors,” said Howland. “As the co-founder and former CEO of Industry Dive, Sean has demonstrated exceptional vision in building a highly respected and rapidly growing B2B media company.”
Howland further noted that Griffey’s expertise in cultivating targeted professional audiences will be instrumental going forward. His ability to deliver insights that create value for both readers and clients is precisely what LSC needs at this stage of its growth.
LSC’s Growth Strategy and Acquisition Plans
Actively Pursuing Strategic Opportunities
LSC continues to evaluate acquisition and growth opportunities. These efforts are designed to expand the company’s capabilities and extend its reach across the life sciences sector. Both partnerships and acquisitions remain active priorities for the leadership team.
Notably, organisations interested in exploring a potential acquisition or partnership may reach out directly.
